Measles virus spread and pathogenesis in genetically modified mice

Journal of Virology

Volumn 72, Issue 9, 1998, Pages 7420-7427

  Mrkic, Branka ^a   Pavlovic, Jovan ^a   Rülicke, Thomas ^a   Volpe, Pietro ^a   Buchholz, Christian J ^a   Hourcade, Dennis ^b   Atkinson, John P ^b   Aguzzi, Adriano ^a   Cattaneo, Roberto ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ARTICLE; CELL SPREADING; DRUG RECEPTOR BINDING; GENE TARGETING; GENETIC ANALYSIS; HISTOPATHOLOGY; LETHALITY; MEASLES VIRUS; MONONUCLEAR CELL; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RECEPTOR AFFINITY; VIRUS INACTIVATION; VIRUS MUTATION;

EID: 0031870670     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.9.7420-7427.1998     Document Type: Article

References (60)

1. Albrecht, P., D. Lorenz, M. J. Klutch, J. H. Vickers, and F. A. Ennis. 1980. Fatal measles infection in marmosets: pathogenesis and prophylaxis. Infect. Immun. 27:969-978.
2. Buchholz, C. J., D. Gerlier, A. Hu, T. Cathomen, M. K. Liszewski, J. P. Atkinson, and R. Cattaneo. 1996. Selective expression of a subset of measles virus receptor-competent CD46 isoforms in human brain. Virology 217:349-355.
3. Buchholz, C. J., D. Koller, P. Devaux, C. Mumenthaler, J. Schneider-Schaulies, W. Braun, D. Gerlier, and R. Cattaneo. 1997. Mapping of the primary binding site of measles virus to its receptor CD46. J. Biol. Chem. 272:22072-22079.
4. Buchholz, C. J., U. Schneider, P. Devaux, D. Gerlier, and R. Cattaneo. 1996. Cell entry by measles virus: long hybrid receptors uncouple binding from membrane fusion. J. Virol. 70:3716-3723.
5. Bueler, H., M. Fischer, Y. Lang, H. Bluethmann, H. P. Lipp, S. J. DeArmond, S. B. Prusiner, M. Aguet, and C. Weissmann. 1992. Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature 356:577-582.
6. Carrigan, D. R., and K. K. Knox. 1990. Identification of interferon-resistant subpopulations in several strains of measles virus: positive selection by growth of the virus in brain tissue. J. Virol. 4:1606-1615.
7. Cathomen, T., B. Mrkic, D. Spehncr, R. Drillien, R. Naef, J. Pavlovic, A. Aguzzi, M. A. Billeter, and R. Cattaneo. 1998. A matrix-less measles virus is infectious and elicits extensive cell fusion: consequences for pathogenesis in the brain. EMBO J. 17:3899-3908.
8. Cathomen, T., H. Naim, and R. Cattaneo. 1998. Measles viruses with altered envelope protein cytoplasmic tails gain cell fusion competence. J. Virol. 72: 1224-1234.
9. Cattaneo, R., G. Rebmann, A. Schmid, K. Baczko, V. ter Meulen, and M. A. Billeter. 1987. Altered transcription of a defective measles virus genome derived from a diseased human brain. EMBO J. 6:681-688.
10. Cattaneo, R., A. Schmid, D. Eschle, K. Baczko, V. ter Meulen, and M. A. Billeter. 1988. Biased hypermutation and other genetic changes in defective measles viruses in human brain infections. Cell 55:255-265.
11. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
12. Cui, W., D. Hourcade, T. Post, A. C. Greenlund, J. P. Atkinson, and V. Kumar. 1993. Characterization of the promoter region of the membrane cofactor protein (CD46) gene of the human complement system and comparison to a membrane cofactor protein-like genetic element. J. Immunol. 151:4137-4146.
13. Dörig, R. E., A. Marcil, A. Chopra, and C. D. Richardson. 1993. The human CD46 molecule is a receptor for measles virus (Edmonston strain). Cell 75: 295-305.
14. Fugier-Vivier, I., C. Servet-Delprat, P. Rivailler, M. C. Rissoan, Y. J. Liu, and C. Rabourdin-Combe. 1997. Measles virus suppresses cell-mediated immunity by interfering with the survival and functions of dendritic and T cells. J. Exp. Med. 186:813-823.
15. Gascon, G. G. 1996. Subacute sclerosing panencephalitis. Semin. Pediatr. Neurol. 3:260-269.
16. Griffin, D. E., J. Mullinix, O. Narayan, and R. T. Johnson. 1974. Age dependence of viral expression: comparative pathogenesis of two rodentadapted strains of measles virus in mice. Infect. Immun. 9:690-695.
17. Horvat, B., P. Rivailler, G. Varior-Krishnan, A. Cardoso, D. Gerlier, and C. Rabourdin-Combe. 1996. Transgenic mice expressing human measles virus (MV) receptor CD46 provide cells exhibiting different permissivities to MV infections. J. Virol. 70:6673-6681.
18. Hourcade, D., A. D. Garcia, T. W. Post, M. P. Taillon, V. M. Holers, L. M. Wagner, N. S. Bora, and J. P. Atkinson. 1992. Analysis of the human regulators of complement activation (RCA) gene cluster with yeast artificial chromosomes (YACs). Genomics 12:289-300.
19. Johnstone, R. W., B. E. Loveland, and I. F. McKenzie. 1993. Identification and quantification of complement regulator CD46 on normal human tissues. Immunology 79:341-347.
20. Jonsson, A. B. 1998, Personal communication.
21. Källström, H., M. K. Liszewski, J. P. Atkinson, and A. B. Jonsson. 1997. Membrane cofactor protein (MCP or CD46) is a cellular pilus-receptor for pathogenic Neisseria. Mol. Microbiol. 25:639-647.
22. Karp, C. L., M. Wysocka, L. M. Wahl, J. M. Ahearn, P. J. Cuomo, B. Sherry, G. Trinchieri, and D. E. Griffin. 1996. Mechanism of suppression of cellmediated immunity by measles virus. Science 273:228-231.
23. Kato, A., K. Kiyotani, Y. Sakai, T. Yoshida, and Y. Nagai. 1997. The paramyxovirus, Sendai virus, V protein encodes a luxury function required for viral pathogenesis. EMBO J. 16:578-587.
24. Khatib, R., M. Siddique, and M. Abbass. 1993. Measles associated hepatobiliary disease: an overview. Infection 21:112-114.
25. Koike, S., J. Aoki, and A. Nomoto. 1994. Transgenic mouse for the study of poliovirus pathogenicity, p. 463-480. In E. Wimmer (ed.), Cellular receptors for animal viruses. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N. Y.
26. Laird, P. W., A. Zijderveld, K. Linders, M. A. Rudnicki, R. Jaenisch, and A. Berns. 1991. Simplified mammalian DNA isolation procedure. Nucleic Acids Res. 19:4293.
27. Lecouturier, V., J. Fayolle, M. Caballero, J. Carabaña, M. L. Celma, R. Fernandez-Muñoz, T. F. Wild, and R. Buckland. 1996. Identification of two amino acids in the hemagglutinin glycoprotein of measles virus (MV) that govern hemadsorption, HeLa cell fusion, and CD46 downregulation: phenotypic markers that differentiate vaccine and wild-type MV strains. J. Virol. 70:4200-4204.
28. Leapardi, R., T. Hyypia, and R. Vainionpaa. 1992. Effect of interferon-alpha on measles virus replication in human peripheral blood mononuclear cells. APMIS 100:125-131.
29. Liebert, U. G., and D. Finke. 1995. Measles virus infections in rodents. Curr. Top. Microbiol. Immunol. 191:149-166.
30. Liebert, U. G., S. G. Flanagan, S. Loffler, K. Baczko, V. ter Meulen, and B. K. Rima. 1994. Antigenic determinants of measles virus hemagglutinin associated with neurovirulence. J. Virol. 68:1486-1493.
31. Liszewski, M. K., T. W. Post, and J. P. Atkinson. 1991. Membrane cofactor protein (MCP or CD46): newest member of the regulators of complement ativation gene cluster. Annu. Rev. Immunol. 9:431-455.
32. McChesney, M. B., C. J. Miller, P. A. Rota, Y. D. Zhu, L. Antipa, N. W. Lerrche, R. Ahmed, and W. J. Bellini. 1997. Experimental measles. I. Pathogenesis in the normal and the immunized host. Virology 233:74-84.
33. Moench, T.R., D. E. Griffin, C. R. Obriechrt, A.J. Vaisberg, and R. T. Johnson. 1988. Acute measles in patients with and without neurological involvement: distribution of measles virus antigen and RNA. J. Infect. Dis. 158:433-442.
34. Montoliu, L., A. Schedl, G. Kelsey, P. Lichter, Z. Larin, H. Lehrach, and G. Schutz. 1993. Generation of transgenic mice with yeast artificial chromosomes. Cold spring Harbor Symp. Quant. Biol. 58:55-62.
35. Müller, U., U. Steinhoff, L. F. Reis, S. Hemmi, J. Pavlovic, K. M. Zinkernagel, and M. Aguet. 1994. Functional role of type I and type II interferons in antiviral defense. Science 264:1918-1921.
36. Naniche, D., G. Varior-Krishnan, F. Cervoni, T. F. Wild, B. Rossi, C. Rabourdin-Combe, and D. Gerlier. 1993. Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus. J. Virol. 67:6025-6032.
37. Niewiesk, S., I. Eisenhuth, A. Fooks, C. S. Clegg, J.-J. Schnorr, S. Schneider-Schaulies, and V. ter Meulen. 1997. Measles virus-induced immune suppression in the cotton rat (Sigmodon hispidus) model depends on viral glycoproteins. J. Virol. 71:7214-7219.
38. Niewiesk, S., U. Brinckmann, B. Bankamp, S. Sirak, U. G. Liebert, and V. ter Meulen. 1993. Susceptibility to measles virus-induced encephalitis in mice correlates with impaired antigen presentation to cytotoxic T lymphocytes. J. Virol. 67:75-81.
39. Niewiesk, S., J. Schneider-Schaulies, H. Ohnimus, C. Jassoy, S. Schneider-Schaulies, L. Diamond, J. S. Logan, and V. ter Meulen. 1997. CD46 expression does not overcome the intracellular block of measles virus replication in transgenic rats. J. Virol. 71:7969-7973.
40. Norrby, E., and M. N. Oxman. 1990. Measles virus, p. 1013-1044. In B. N. Fields and D. M. Knipe (ed.), Virology. Raven Press Ltd., New York, N.Y.
41. Okada, N., M. K. Liszewski, J. P. Atkinson, and M. Caparon. 1995. Membrane cofactor protein (CD46) is a keratinocyte receptor for the M protein of the group A streptococcus. Proc. Natl. Acad. Sci. USA 92:2489-2493.
42. Peterson, K. R., C. H. Clegg, Q. Li, and G. Stamatoyannopoulos. 1997. Production of transgenic mice with yeast artificial chromosomes. Trends Genet. 13:61-66.
43. Radecke, F., and M. A. Billeter. 1995. Appendix: measles virus antigenome and protein consensus sequences. Curr. Top. Microbiol. Immunol. 191:181-192.
44. Radecke, F., and M. A. Billeter. 1996. The nonstructural C protein is not essential for multiplication of Edmonston B strain measles virus in cultured cells. Virology 217:418-421.
45. Radecke, F., P. Spielhofer, H. Schneider, K. Kaelin, M. Huber, C. Dotsch, G. Christiansen, and M. A. Billeter. 1995. Rescue of measles viruses from cloned DNA. EMBO J. 14:5773-5784.
46. Rall, G. F., M. Manchester, L. R. Daniels, E. M. Callahan, A. R. Belman, and M. B. A. Oldstone. 1997. A transgenic mouse model for measles virus infection of the brain. Proc. Natl. Acad. Sci. USA 94:4659-4663.
47. Ren, R. B., F. Costantini, E. J. Gorgacz, J. J. Lee, and V. R. Racaniello. 1990. Transgenic mice expressing a human poliovirus receptor: a new model for poliomyelitis. Cell 63:353-362.
48. Schedl, A., Z. Larin, L. Montoliu, E. Thies, G. Kelsey, H. Lehrach, and G. Schutz. 1993. A method for the generation of YAC transgenic mice by pronuclear microinjection. Nucleic Acids Res. 21:4783-4787.
49. Schleuder, J., J. J. Schnorr, P. Spielhofer, T. Cathomen, R. Cattaneo, M. A. Billeter, V. ter Meulen, and S. Schneider-Schaulies. 1996. Interaction of measles virus glycoproteins with the surface of uninfected peripheral blood lymphocytes induces immunosuppression in vitro. Proc. Natl. Acad. Sci. USA 93:13194-13199.
50. Schneider, H., K. Kaelin, and M. A. Billeter. 1997. Recombinant measles viruses defective for RNA editing and V protein synthesis are viable in cultured cells. Virology 227:314-322.
51. Schneider-Schaulies, J., L. M. Dunster, F. Kobune, B. Rima, and V. ter Meulen. 1995. Differential downregulation of CD46 by measles virus strains. J. Virol. 69:7257-7259.
52. Schneider-Schaulies, J., J. J. Schnorr, U. Brinckmann, L. M. Dunster, K. Baczko, U. G. Liebert, S. Schneider-Schaulies, and V. ter Meulen. 1995. Receptor usage and differential downregulation of CD46 by measles virus wild-type and vaccine strains. Proc. Natl. Acad. Sci. USA 92:3943-3947.
53. Schneider-Schaulies, J., J. J. Schnorr, J. Schleuder, L. M. Dunster, S. Schneider-Schaulies, and V. ter Meulen. 1996. Receptor (CD46) modulation and complement-mediated lysis of uninfected cells after contact with measles virus-infected cells. J. Virol. 70:255-263.
54. Spielhofer, P. 1995. Ph.D. thesis. University of Zürich, Zürich, Switzerland.
55. ter Meulen, V., J. R. Stephenson, and H. W. Kreth. 1983. Subacute sclerosing panencephalitis, p. 105-159. In H. Fraenkel-Conrat and R. R. Wagner (ed.), The viruses, vol. 18. Virus-host interactions: receptors, persistence, and neurological diseases. Plenum Press, New York, N.Y.
56. Thorley, B. R., J. Milland, D. Christiansen, M. B. Lanteri, B. McInnes, I. Moeller, P. Rivailler, B. Horvat, C. Rabourdin-Combe, D. Gerlier, I. F. McKenzie, and B. E. Loveland. 1997. Transgenic expression of a CD46 (membrane cofactor protein) minigene: studies of xenotransplantation and measles virus infection. Eur. J. Immunol. 27:726-734.
57. Trescol-Biemont, M. C., S. Leonov, C. Rabourdin-Combe, and D. Gerlier. 1995. Quantification of measles virus by a virus receptor-dependent and haemagglutinin-specific T cell stimulation assay. J. Immunol. Methods 187:253-258.
58. van Binnendijk, R. S., R. W. J. van der Heijden, and A. D. M. E. Osterhaus. 1995. Monkeys in measles research. Curr. Top. Mol. Immunol. 191:135-148.
59. Volpe, P. 1997. M.Sc. thesis. University of Zürich, Zürich, Switzerland.
60. Yalaz, K., B. Anlar, F. Oktem, S. Aysun, S. Ustacelebi, O. Gurcay, K. Gucuyener, and Y. Renda. 1992. Intraventricular interferon and oral inosiplex in the treatment of subacute sclerosing panencephalitis. Neurology 42: 488-491.